Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MITOCHONDRIAL DNA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MITOCHONDRIAL DNA is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with ALS, Aging, Als. Connected to 869 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | MITOCHONDRIAL DNA |
| Primary Expression | Spinal Cord, Substantia Nigra, Hippocampus |
| Pathways | Mitophagy, CGAS-STING, Autophagy, Cgas/Sting Dna Sensing Pathway, Nf-Κb |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis, Ataxia |
| Interactions | A2M, AGING, AHR, AIM2, AKT, ALS |
| KG Connections | 1263 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
graph TD
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"associated"| Alzheimer["Alzheimer"]
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"associated"| Als["Als"]
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"interacts"| Tumor["Tumor"]
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"activates"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"activates"| Als_1["Als"]
MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"] -->|"activates"| Inflammation["Inflammation"]
DHCR24["DHCR24"] -->|"interacts"| MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"]
EIF2AK2["EIF2AK2"] -->|"interacts"| MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"]
LMNA["LMNA"] -->|"interacts"| MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"]
STING["STING"] -->|"activates"| MITOCHONDRIAL_DNA["MITOCHONDRIAL DNA"]
style MITOCHONDRIAL_DNA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Mitochondrial Function | activates | pathway | 1.00 |
| Als | associated_with | disease | 1.00 |
| STING | activates | gene | 1.00 |
| DNA | associated_with | gene | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| MTDNA | activates | gene | 1.00 |
| cGAS | activates | protein | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| DNA | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Mitophagy | activates | pathway | 1.00 |
| Inflammation | activates | disease | 1.00 |
| CGAS | activates | gene | 1.00 |
| MITOCHONDRIA | activates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| MITOCHONDRIA | associated_with | gene | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| MTDNA | associated_with | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 1.00 |
| DNA | causes | gene | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| MTDNA | causes | gene | 1.00 |
| GENES | associated_with | gene | 1.00 |
| DNA | inhibits | gene | 1.00 |
| CGAS-STING | activates | gene | 1.00 |
| Mitochondrial Function | therapeutic_target | pathway | 1.00 |
| Parkinson | activates | disease | 0.95 |
| Cancer | therapeutic_target | disease | 0.95 |
| Tumor | activates | disease | 0.95 |
| Als | inhibits | disease | 0.95 |
| Inflammation | associated_with | disease | 0.95 |
| cGAS-STING Pathway | activates | pathway | 0.92 |
| Cgas-Sting Pathway | activates | pathway | 0.90 |
| cGAS-STING pathway | activates | pathway | 0.90 |
| CGAS-STING | activates | pathway | 0.90 |
| cGAS/STING | activates | pathway | 0.90 |
| CGAS | activates | protein | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| AUTOPHAGY | activates | gene | 0.90 |
| DRP1 | activates | gene | 0.90 |
| Alzheimer | therapeutic_target | disease | 0.85 |
| innate immune response | associated_with | process | 0.85 |
| Diabetes | activates | disease | 0.85 |
| Cgas/Sting Dna Sensing Pathway | activates | pathway | 0.85 |
| Aging | activates | disease | 0.85 |
| Alzheimer | activates | disease | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURODEGENERATION | associated_with | gene | 1.00 |
| MITOPHAGY | activates | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| PINK1 | activates | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| TFAM | binds | protein | 0.95 |
| TARDBP | causes | gene | 0.95 |
| TFAM | involved_in | gene | 0.95 |
| TARDBP | associated_with | gene | 0.95 |
| TDP-43 | causes | protein | 0.90 |
| TDP-43 | triggers_release_via | protein | 0.90 |
| cGAS-STING Pathway | associated_with | pathway | 0.90 |
| Mptp | mediates | mechanism | 0.90 |
| TDP-43 | associated_with | protein | 0.90 |
| MPTP | mediates | protein | 0.90 |
| MAPL | promotes | protein | 0.90 |
| TDP43 | causes | entity | 0.90 |
| MAPL | transports | gene | 0.90 |
| oxidative stress | damages | process | 0.90 |
| OXIDATIVE STRESS | activates | gene | 0.90 |
| ROS | activates | gene | 0.90 |
| HSV-1 | degrades | entity | 0.85 |
| Mitophagy | associated_with | process | 0.85 |
| TFAM | regulates | protein | 0.80 |
| TFAM | binds | protein | 0.80 |
| LRRK2 | interacts_with | gene | 0.80 |
| TFAM | modulates | protein | 0.80 |
| PLD3 | degrades | gene | 0.80 |
| FOXO3 | downregulates | protein | 0.80 |
| 1800 MHz radiofrequency radiation | induces_oxidative_damage | process | 0.80 |
| Hsv-1 | degrades | entity | 0.80 |
| SOD1 | regulates | gene | 0.80 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.80 |
| MITOCHONDRIAL DYSFUNCTION | causes | gene | 0.80 |
| MITOCHONDRIAL DYSFUNCTION | inhibits | gene | 0.80 |
| NF-ΚB | activates | gene | 0.80 |
| PARKINSON'S DISEASE | activates | gene | 0.80 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.80 |
| ROS | therapeutic_target | gene | 0.80 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.70 |
| MITOPHAGY | inhibits | gene | 0.70 |
| INFLAMMATION | regulates | gene | 0.70 |
| APOPTOSIS | associated_with | gene | 0.70 |
| POLG | activates | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| DNA | activates | gene | 0.70 |
| ALZHEIMER | therapeutic_target | gene | 0.70 |
| TFAM | regulates | protein | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu | 0.803 | neurodegeneration | What are the mechanisms by which gut mic |
| Senescent Cell Mitochondrial DNA Release | 0.742 | neurodegeneration | Senolytic therapy for age-related neurod |
| Mitochondrial DNA Damage and cGAS-STING Activation Induces M | 0.520 | neurodegeneration | What molecular mechanisms drive microgli |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Proposed experiment from debate on Senolytics targeting p16/p21+ senes | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $180,000 |
| Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
| cGAS-STING Pathway Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| Mixed Pathology Effects on Parkinson's Disease Progression and Treatme | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| NLRP3 Inflammasome Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Regulated Necrosis Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Traumatic Brain Injury and Alzheimer's Disease Relationship | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Viral Infections and Alzheimer's Disease — causal mechanisms and thera | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] | Yu CH, Davidson S, Harapas CR, Hilton JB | Cell | 2020 | 2 |
| Past, present and future perspectives on the science of aging. [PMID:41566049] | Fabrisia Ambrosio; Maxim N Artyomov; Ste | Nature aging | 2026 | 0 |
| Stimuli-responsive nanoplatforms for precision activation of the STING pathway i [PMID:41668757] | ["Bi D", "Yang X", "Wang Y", "Yong J", " | Frontiers in immunology | 2026 | 0 |
| Decoding senescent drivers in Alzheimer's disease: From bench to bedside. [PMID:41344577] | ["Zhou R", "Lin X", "Liao Z", "Lin J", " | Ageing research reviews | 2026 | 0 |
| Role of NEIL1 in genome maintenance. [PMID:40010204] | ["McCullough A", "Minko I", "Luzadder M" | DNA repair | 2025 | 0 |
| Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] | ["Ranjitha V", "Kumar A", "Kaalappa P"] | Pharmaceutical research | 2025 | 0 |
| Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven imm [PMID:40203808] | ["Lai P", "Liu L", "Bancaro N", "Troiani | Immunity | 2025 | 0 |
| Apheresis for senescence: Targeting the senescence-associated secretory phenotyp [PMID:40651559] | ["Akgun Y"] | Ageing research reviews | 2025 | 0 |
| Methodological influences on circulating cell-free-mitochondrial and nuclear DNA [PMID:40080226] | ["Daubermann C", "Herhaus B", "Neuberger | Molecular biology reports | 2025 | 0 |
| Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflamma [PMID:40902587] | ["Song Z", "Xie X", "Chen Y", "Zhang B", | Immunity | 2025 | 0 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| Antileukemic potential of methylated indolequinone MAC681 through immunogenic ne [PMID:38704604] | ["Orlikova-Boyer B", "Lorant A", "Gajula | Biomarker research | 2024 | 0 |
| Enhancing Radiofrequency Ablation for Hepatocellular Carcinoma: Nano-Epidrug Eff [PMID:39548919] | ["Li X", "Liu Y", "Ke J", "Wang Z", "Han | Advanced materials (Deerfield | 2024 | 0 |
| The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellul [PMID:39490400] | Zhang Y, Zou M, Wu H, Zhu J, Jin T | Neurobiology of disease | 2024 | 0 |
| mtDNA release promotes cGAS-STING activation and accelerated aging of postmitoti [PMID:39039044] | ["Li Y", "Cui J", "Liu L", "Hambright W" | Cell death & disease | 2024 | 0 |
| Senescent glia link mitochondrial dysfunction and lipid accumulation. [PMID:38839958] | ["Byrns C", "Perlegos A", "Miller K", "J | Nature | 2024 | 0 |
| Apoptotic stress causes mtDNA release during senescence and drives the SASP. [PMID:37821702] | ["Victorelli S", "Salmonowicz H", "Chapm | Nature | 2023 | 0 |
| Exposome and unhealthy aging: environmental drivers from air pollution to occupa [PMID:37688657] | Pandics T, Major D, Fazekas-Pongor V, Sz | GeroScience | 2023 | 0 |
| cGAS-STING drives ageing-related inflammation and neurodegeneration. [PMID:37532932] | Gulen MF, Samson N, Keller A, Schwabenla | Nature | 2023 | 0 |
| Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STI [PMID:36964253] | ["Kim J", "Kim H", "Chung J"] | Experimental & molecular medic | 2023 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity